Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Advaxis files investigational new drug application for Lovaxin C

Advaxis Inc. completed its filing of a new investigational new drug ("IND") application with the U.S. Food and Drug Administration ("FDA"). This filing follows the successful completion of a Phase I study overseas.

20 May 2008

New data reveals impact of deadly human papillomavirus in Latin America, Caribbean

Thirty-three thousand women in Latin America and the Caribbean die each year of preventable cervical cancer, caused by a virus that infects 20 percent of men and women in the region and as many as 30 percent of the youngest women, according to a new study.

12 May 2008

Starpharma reports positive VivaGel clinical study results

Starpharma Holdings Limited today announced positive results of a clinical trial that achieved all its objectives demonstrating that 3% SPL7013 Gel (VivaGel) was safe and well-tolerated in sexually abstinent women when administered vaginally, twice daily for 14 days.

11 May 2008

Medical research is essential to improving the economy and bettering lives

Health care in the United States is expensive, but its funding is crucial because it also is a major contributor to the economy and can better lives, according to an essay appearing in the June 2008 issue of the Journal of the American Society Nephrology (JASN). Because of the cost of health care, this is not time to shrink the budget at the National Institutes of Health, which funds medical research that leads to potentially curative therapy.

7 May 2008

Mothers less likely to pursue HPV vaccination for youngest daughters

Because the first national study of its kind has found that U.S. mothers report they are less likely to vaccinate daughters under age 13 against human papillomavirus virus (HPV), even though the vaccine is recommended for girls at age 11 and 12, it's incumbent upon the healthcare community to work to improve moms' acceptance of the vaccination for younger daughters, say researchers at Cincinnati Children's Hospital Medical Center who conducted the study. HPV is a sexually transmitted virus known to cause cervical cancer.

30 Apr 2008

Viruses may play a role in lung cancer development

Papers presented at the 1st European Lung Cancer Conference, jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in Geneva, Switzerland highlight emerging evidence that common viruses may contribute to the development of lung cancer.

26 Apr 2008

Surgery successful in removing Indonesian man's disfiguring bark-like warts

An Indonesian man so badly disfigured by warts that he has been dubbed the Tree Man of Java has had surgery to remove the bark like tissue growing from his hands and feet.

16 Apr 2008

Periodontitis and human papillomavirus combined increase risk for tongue cancer

Persons with periodontitis who also are infected with human papillomavirus (HPV) are at increased risk of developing tongue cancer, new research conducted at the University at Buffalo School of Dental Medicine has shown.

7 Apr 2008

New test for cervical cancer

The Pap test has been the standard screening tool for cervical cancer for years -- and it still is.

3 Apr 2008

The body's fight with cervical cancer

The virus responsible for most cases of cervical cancer has a serious weakness which may provide hope for new treatments for the disease.

24 Mar 2008

SWHR statement on CDC report on young women and STDs

Society for Women's Health Research President and CEO Phyllis Greenberger, M.S.W., issued the following statement in response to a Centers for Disease Control and Prevention study released yesterday, which found that one in four females aged 14-19 has a sexually transmitted disease:

14 Mar 2008

New behavioral risk factors for head and neck cancers

Researchers at the Johns Hopkins Kimmel Cancer Center have teased out two distinct sets of risk factors for head and neck cancers, suggesting that there are two completely different kinds of the disease.

12 Mar 2008

Cervarix shows long-term protection from cervical cancer

New data demonstrate that GlaxoSmithKline's cervical cancer candidate vaccine, CERVARIX provides significant protection for women against the four most common cancer- causing human papillomavirus types for nearly six and a half years, the longest duration of protection reported to date.

12 Mar 2008

A quarter of teenage girls in the U.S. have a sex-related disease

The Centers for Disease Control and Prevention (CDC) in the United States has revealed that a quarter of teen girls have a sex-related disease.

11 Mar 2008

Gardasil reduces abnormal Pap test results

A significant drop in abnormal Pap test results happened after girls and women were given a vaccine to prevent cervical cancer, according to a researcher at the University of Alabama at Birmingham (UAB).

10 Mar 2008

Combination vaccine against Ebola and Marburg viruses provides complete protection for monkeys

An experimental, combination vaccine against Ebola and Marburg viruses using virus-like particles (VLPs) provides complete protection against infection in monkeys.

27 Feb 2008

Stress may increase a woman's risk of developing cervical cancer

A woman's daily stress can reduce her ability to fight off a common sexually transmitted disease and increase her risk of developing the cancer it can cause, according to a new study.

18 Feb 2008

HPV-positive head and neck cancer patients fare better than HPV-negative patients

Head and neck cancer patients with HPV-positive tumors tend to survive longer and are more responsive to treatment compared with patients with HPV-negative tumors, according to a study published online February 12 in the Journal of the National Cancer Institute.

13 Feb 2008